Correlation Between Bioatla and Replimune

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bioatla and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bioatla and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bioatla and Replimune Group, you can compare the effects of market volatilities on Bioatla and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bioatla with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bioatla and Replimune.

Diversification Opportunities for Bioatla and Replimune

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Bioatla and Replimune is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Bioatla and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and Bioatla is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bioatla are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of Bioatla i.e., Bioatla and Replimune go up and down completely randomly.

Pair Corralation between Bioatla and Replimune

Given the investment horizon of 90 days Bioatla is expected to under-perform the Replimune. In addition to that, Bioatla is 1.06 times more volatile than Replimune Group. It trades about -0.05 of its total potential returns per unit of risk. Replimune Group is currently generating about 0.05 per unit of volatility. If you would invest  1,123  in Replimune Group on September 19, 2024 and sell it today you would earn a total of  125.00  from holding Replimune Group or generate 11.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bioatla  vs.  Replimune Group

 Performance 
       Timeline  
Bioatla 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bioatla has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Replimune Group 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Replimune Group are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Replimune disclosed solid returns over the last few months and may actually be approaching a breakup point.

Bioatla and Replimune Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bioatla and Replimune

The main advantage of trading using opposite Bioatla and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bioatla position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.
The idea behind Bioatla and Replimune Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years